Trials
Search / Trial NCT06419764

Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery

Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · May 14, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how Chinese herbal treatments can help improve digestive issues in patients who have recently undergone weight loss surgery, known as bariatric surgery. The goal is to see if combining these traditional herbal remedies with modern surgical techniques can lead to better weight loss results and overall health improvements for patients.

To be eligible for this study, participants should be between the ages of 65 and 74, have a body mass index (BMI) of 27.5 or higher, and be preparing for metabolic bariatric surgery. They should also have specific health conditions identified by traditional Chinese medicine, such as Spleen Deficiency and Excess Dampness syndrome. Participants will have the opportunity to receive these herbal treatments, potentially benefiting their recovery process after surgery. It’s important to note that people with certain medical conditions, like diabetes or severe illnesses, as well as pregnant or breastfeeding women, cannot join this trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. BMI ≥ 27.5 kg/m²;
  • 2. Undergoing metabolic bariatric surgery;
  • 3. Traditional Chinese Medicine syndrome differentiation classified as Spleen Deficiency and Excess Dampness syndrome.
  • Exclusion Criteria:
  • 1. Contraindications for metabolic bariatric surgery;
  • 2. Type 1 diabetes;
  • 3. Complicated by other significant systemic diseases, such as severe liver and kidney diseases, malignant tumors, psychiatric disorders, etc;
  • 4. Concurrent use of other medications or treatments that may affect body weight, such as metformin, semaglutide, endoscopic interventions, etc;
  • 5. Pregnant or lactating women.

About China Japan Friendship Hospital

China-Japan Friendship Hospital is a leading clinical research institution dedicated to advancing healthcare through innovative medical research and trials. Established as a collaborative effort between China and Japan, the hospital integrates cutting-edge technology with traditional medical practices, fostering a multidisciplinary approach to patient care and clinical studies. The institution is committed to enhancing therapeutic outcomes and improving patient safety while adhering to rigorous ethical standards. With a diverse team of experienced healthcare professionals and researchers, China-Japan Friendship Hospital plays a pivotal role in addressing global health challenges and contributing to medical knowledge through its extensive clinical trial programs.

Locations

Beijing, , China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0